Pneumococcal conjugate second or third-dose vaccines (PCVc) in Indonesia
Indonesia: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 69.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Indonesia, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Indonesia stood at 69.0%.
The figure is down 1.4% on the previous year and up 1,625.0% over five years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Indonesia peaked at 70.0% in 2024 and was at its lowest, 0.0%, in 2008.
Indonesia ranks 135th of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Indonesia, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 3.0% | — |
| 2020 | 4.0% | +33.3% |
| 2021 | 1.0% | -75.0% |
| 2022 | 6.0% | +500.0% |
| 2023 | 31.0% | +416.7% |
| 2024 | 70.0% | +125.8% |
| 2025 | 69.0% | -1.4% |
Indonesia compared with similar countries
- Indonesia's 69.0% is below the median for upper middle income countries, which is 76.0%, 91% of the median. (57 countries reporting)
- Indonesia's 69.0% is below the median for East Asia & Pacific, which is 81.0%, 85% of the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 0.3% | 0.0% | 3.0% | 10 |
| 2020s | 30.2% | 1.0% | 70.0% | 6 |
Countries ranked near Indonesia
More health data for Indonesia
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4924 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,286 deaths per 1,000 people (2090)
- Number of infants who die before age 1 16,463 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 50 (2025)
- Population ages 00-04, female, annual growth rate -0.5792 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0376 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5519 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Indonesia?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Indonesia was 69.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Indonesia?
- The highest recorded value was 70.0% in 2024.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Indonesia?
- The lowest recorded value was 0.0% in 2008.
- How does Indonesia rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Indonesia ranks 135th out of 194 countries with data for 2025.
- Where does this Indonesia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).